चिली - स्पेनी - ISPC (Instituto de Salud Pública de Chile)

novartis chile s.a. - deferasirox - sin formulas

स्पेन - स्पेनी - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

hikma farmaceutica (portugal) s.a. - folinato calcio - solucion inyectable y para perfusion - 300 mg inyectable 30 ml - folinato calcio 10 mg - folinato de calcio

क्यूबा - स्पेनी - CECMED (Autoridad Reguladora de Medicamentos, Equipos y Dispositivos Médicos)

biozenta lifescience pvt. ltd. - hidroxiurea - cápsula - 500 mg

यूरोपीय संघ - स्पेनी - EMA (European Medicines Agency)

les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - agentes antineoplásicos - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.